More than 10 years of industry 4.0 in the Netherlands: an opinion on promises, achievements, and emerging challenges von Martinetti, A., Nizamis, K., Chemweno, P., Goulas, C., van Dongen, L.A.M., Gibson, I., Thiede, S., Lutters, E., Vaneker, T., Bonnema, G. M.

Volltext

Designing a problem analysis toolkit in the context of humanitarian engineering von Jakubeit, N. (Nina), Richards, C. (Carithea), Martinetti, A. (Alberto)

Volltext

Temozolomide and irinotecan (TEMIRI regimen) as salvage treatment of irinotecan-sensitive advanced colorectal cancer patients bearing MGMT methylation von Morano, F., Corallo, S., Niger, M., Barault, L., Milione, M., Berenato, R., Moretto, R., Randon, G., Antista, M., Belfiore, A., Raimondi, A., Nichetti, F., Martinetti, A., Battaglia, L., Perrone, F., Pruneri, G., Falcone, A., Di Bartolomeo, M., de Braud, F., Di Nicolantonio, F., Cremolini, C., Pietrantonio, F.

Volltext

Supporting maintenance operators using augmented reality decision-making: visualize, guide, decide & track von Scheffer, S.E. (Sara), Martinetti, A. (Alberto), Damgrave, R.G.J. (Roy), van Dongen, L.A.M. (Leo)

Volltext

Does dose modification affect efficacy of first-line pazopanib in metastatic renal cell carcinoma? von Fuca', G, Verzoni, E, Ratta, R, Luca, P, Martinetti, A, Mennitto, A, Grassi, P, Procopio, G

Volltext

Prospective translational study investigating circulating predictors of outcome to first-line pazopanib in patients with metastatic renal cell carcinoma (mRCC) von Grassi, P, Verzoni, E, Ratta, R, Martinetti, A, Montone, R, Tagliabue, E, de Braud, F, Procopio, G

Volltext

Analysis of circulating biomarkers in a randomized phase II trial of maintenance oral metronomic vinorelbine in advanced NSCLC following platinum-based chemotherapy: A correlative... von Boeri, M., Nichetti, F., Porcu, L., Torri, V., Del Conte, A., Martinetti, A., Sottotetti, E., Vattemi, E., Verderame, F., Garassino, M.C., Cavanna, L., Tuzi, A., Irtelli, L., de Braud, F.G.M., Platania, M.

Volltext

Cellular Effects and Antitumor Activity of RET Inhibitor RPI-1 on MEN2A-Associated Medullary Thyroid Carcinoma von Cuccuru, Giuditta, Lanzi, Cinzia, Cassinelli, Giuliana, Pratesi, Graziella, Tortoreto, Monica, Petrangolini, Giovanna, Seregni, Ettore, Martinetti, Antonia, Laccabue, Diletta, Zanchi, Chiara, Zunino, Franco

Volltext

A framework for selecting and assessing wearable sensors deployed in safety critical scenarios von Houghton, R, Martinetti, A, Majumdar, A

Volltext

Clinical significance of blood chromogranin A measurement in neuroendocrine tumours von Seregni, E., Ferrari, L., Bajetta, E., Martinetti, A., Bombardieri, E.

Volltext

PEOPLE (NCT03447678), a first-line phase II pembrolizumab trial, in negative and low PD-L1 advanced NSCLC: clinical outcomes and association with circulating immune biomarkers von Lo Russo, G., Sgambelluri, F., Prelaj, A., Galli, F., Manglaviti, S., Bottiglieri, A., Di Mauro, R.M., Ferrara, R., Galli, G., Signorelli, D., De Toma, A., Occhipinti, M., Brambilla, M., Rulli, E., Triulzi, T., Torelli, T., Agnelli, L., Brich, S., Martinetti, A., Dumitrascu, A.D., Torri, V., Pruneri, G., Fabbri, A., de Braud, F., Anichini, A., Proto, C., Ganzinelli, M., Mortarini, R., Garassino, M.C.

Volltext

416 Variant Alleles in Factor V Leiden (FVL), Prothrombin, Plasminogen Activator Inhibitor-1 (PAI-1) or Methylenetetrahydrofolate Reductase (MTHFR) and risk of thromboembolic event... von Falvella, F.S, Cremolini, C, Miceli, R, Nichetti, F, Cheli, S, Antoniotti, C, Infante, G, Martinetti, A, Loupakis, F, Bartolomeo, M. Di, Marmorino, F, Sottotetti, E, Bossi, I, Berenato, R, Caporale, M, Niger, M, Colombo, A, Braud, F. De, Clementi, E, Pietrantonio, F

Volltext

Efficacy of a chemotherapy combination for the treatment of metastatic neuroendocrine tumours von Bajetta, E., Ferrari, L., Procopio, G., Catena, L., Ferrario, E., Martinetti, A., Di Bartolomeo, M., Buzzoni, R., Celio, L., Vitali, M., Beretta, E., Seregni, E., Bombardieri, E.

Volltext

6137 POSTER Biological Analysis of Phase II Study Evaluating the Activity of Cetuximab Combined to Oxaliplatin and Fluoropirimidine (TEGAFOX-E) as First Line Treatment in Metastati... von Bartolomeo, M. Pi, Dotti, K.F, Pietrantonio, F, Perrone, F, Martinetti, A, Pilotti, S, Lampis, A, Bertan, C, Buzzoni, R, Bajetta, E

Volltext

Phase II study of pemetrexed disodium (Alimta®) administered with oral folic acid in patients with advanced gastric cancer von Bajetta, E., Celio, L., Buzzoni, R., Ferrari, L., Marchianò, A., Martinetti, A., Longarini, R., Becerra, C., Ilardi, C., John, W.

Volltext

Osteoprotegerin and osteopontin serum values in postmenopausal advanced breast cancer patients treated with anastrozole von Martinetti, A, Bajetta, E, Ferrari, L, Zilembo, N, Seregni, E, Del Vecchio, M, Longarini, R, La Torre, I, Toffolatti, L, Paleari, D, Bombardieri, E

Volltext

Learning from strangers: transferability of current principles for designing inclusive area-based settlements to learning factories in resource-limited settings von Martinetti, A. (Alberto), Trauernicht, N. (Nina), Chemweno, P.K. (Peter)

Volltext

Design guidelines for HAWT / VAWT decision-making in the context of underserved communities von Trauernicht, N. (Nina), Miguda, H. (Henry), Martinetti, A. (Alberto)

Volltext

272P Modulation of systemic and intratumor metabolism predicts response to fasting-mimicking diet plus chemotherapy in patients with early TNBC von Ligorio, F., Vingiani, A., Torelli, T., Sposetti, C., Provenzano, L., Fotia, G., Belfiore, A., Ferraris, C., Scaperrotta, G., Depretto, C., Martinetti, A., Bianchi, G.V., Capri, G., Folli, S., Minucci, S., Foiani, M., Pagani, M., De Braud, F.G.M., Pruneri, G., Vernieri, C.

Volltext

Disentangling large scale technological projects: learning from ERTMS roll-out case study in the Netherlands von Abbas, Y, Martinetti, A, Houghton, R, Majumdar, A

Volltext